Trials / Unknown
UnknownNCT02371096
Comparative Pharmacokinetic Trial of RGB-03 and MabThera
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Gedeon Richter Plc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- —
Summary
Pharmacokinetic properties, efficacy, safety and tolerability of RGB-03 and MabThera will be compared in patients suffering from Rheumatoid Arthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MabThera (rituximab) | |
| DRUG | RGB-03 |
Timeline
- Primary completion
- 2016-06-01
- First posted
- 2015-02-25
- Last updated
- 2015-02-25
Source: ClinicalTrials.gov record NCT02371096. Inclusion in this directory is not an endorsement.